Superstar Peptides

Status: active (equity deal) Stage: build phase — site live, iterating on B2C funnel + B2B analysis Decision maker: Tavia (no contact info — handled directly through Cynthia) MRR / deal size: $0 cash — equity arrangement Started: 2026-04-30 (workspace created; site already running on our infra) Last touched: 2026-04-30

Profile

DTC + B2B peptide brand co-built with Tavia on equity. We're building both sides:

• B2C: the best consumer peptide site — Cynthia's AI-medicine biometrics flow (BioReveal: skin/body/vitals/voice/chat) as the lead-gen funnel
• B2B: sell into clinics that need 1099 injectable rep coverage. We already have deep data on this from running Bradley's 1099 aesthetics rep staffing (paid engagement) — clinic universe, distributor saturation, IC criteria. That same dataset feeds the B2B peptide play.

What we're doing for them

• Owning + iterating the live site at peptides.cynthiaconcierge.com
• Wiring the BioReveal AI biometrics flow as the B2C lead-gen funnel
• Producing a B2B analysis page leveraging Bradley/aesthetics-rep data → distribute to clinic operators
• Operating the FastAPI backend (chat, skin analysis, vitals, voice synth) on PM2 :3401

North star for this engagement

Build both a B2B and B2C peptide brand and ride the wave of the future of medicine. Two sides, one platform.

Why this works (cross-leverage)

We already know the clinic / 1099 injectable side cold because Bradley pays us to source 1099 aesthetic reps (~/vault/clients/bradley/). Reuse: rep universe, distributor saturation playbook, IC scoring, outreach infrastructure — all retargetable from "find reps for clinics" to "sell peptides to those same clinics."

Context links

• Live site: https://peptides.cynthiaconcierge.com
• Original Vercel build: https://superstar-peptides.vercel.app
• Code: ~/projects/superstar-peptides/
• Backend: FastAPI on 127.0.0.1:3401 (PM2 service cynthia-peptide-bio-api)
• Nginx: ~/config/nginx/peptides.cynthiaconcierge.com
• B2B analysis target: https://analysis.cynthiaconcierge.com/superstar-peptides (not yet published)
• Cross-reference: ~/vault/clients/bradley/ (1099 injectable rep data feeds B2B side)

Folder map (consolidated 2026-06-10)

Everything peptides-related now lives in (or is linked from) this folder:

• analyses/ — all analysis docs, incl. the standalone HTMLs (peptides.html, superstar-peptides-b2b.html)
• analyses/peptidebiz-models-2026-06/ — the 14 PeptideBiz financial-model files from June 6–7 (COGS scenarios, affiliate economics, $80k→$1M timeline, FOR-TAVIA summary) — moved here from ~/ARK Workspace/
• data/incoming-assets/ — investor brief PDF, PeptideBiz price sheet, design zips, mac-transfer archive — moved here from ~/incoming-screenshots/
• code/ — symlinks to the live code in ~/projects/ (superstar-peptides, -v2, -app). Do NOT move the real folders: nginx serves superstarpeptides.ai, superstarwellness.ai, and peptides.cynthiaconcierge.com directly from those paths.
• services/ — symlinks to ~/services/peptide-bio-api and ~/services/peptide-push-engine (PM2 services, currently not running)

Open threads

• Define site changes — feature list + priority for the B2C build-out
• Define B2B analysis scope: which Bradley/aesthetics datasets to surface, what story to tell clinic owners
• Decide go-to-market sequence: B2C funnel first vs B2B clinic outreach first vs parallel

How they like to communicate

TBD — Tavia handles direct, no contact info needed for now (equity deal, working through Cynthia)